LTZ Therapeutics: Funding, Investors & Team (Oct 2026)
LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.
LTZ Therapeutics has raised $98.0M across 4 funding rounds on record, the most recent an undisclosed round of $38.0M announced in May 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
LTZ Therapeutics Company Profile and Key Stats
Latest funding round on record: May 2026.
LTZ Therapeutics Funding Rounds
1 of 4 rounds was announced without a disclosed amount and is excluded from the total.
LTZ Therapeutics raised $20.0M in a Series A announced in Jul 2024.
9 months later, a Series A of $40.0M was announced in Apr 2025.
3 months later, an undisclosed round was announced in Jul 2025 with no disclosed amount.
10 months later, an undisclosed round of $38.0M was announced in May 2026.
LTZ Therapeutics Founders and Leadership Team
Contact details for the LTZ Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →LTZ Therapeutics Funding Compared to Other Biotechnology Startups
LTZ Therapeutics' latest round of $38.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like LTZ Therapeutics in Biotechnology and San Francisco
Companies Similar to LTZ Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
LTZ Therapeutics Funding FAQs
What does LTZ Therapeutics do?
LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.
How much funding has LTZ Therapeutics raised?
LTZ Therapeutics has raised $98.0M across 4 rounds on record. The most recent is an undisclosed round of $38.0M announced in May 2026.
When did LTZ Therapeutics last raise funding?
LTZ Therapeutics' most recent funding round on record is an undisclosed round of $38.0M, announced in May 2026.
Who founded LTZ Therapeutics?
FundedIQ lists Robert Li (Founder) at LTZ Therapeutics.
Where is LTZ Therapeutics headquartered?
LTZ Therapeutics is based in San Francisco, California, United States.
How many employees does LTZ Therapeutics have?
LTZ Therapeutics is in the 11-50 employee band.
How does LTZ Therapeutics' funding compare to other Biotechnology startups?
LTZ Therapeutics' latest round of $38.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's LTZ Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for LTZ Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.